Vaccinex Announces $13.8 Million Private Placement
31 juil. 2019 07h30 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and...
Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
18 juil. 2019 07h00 HE
|
Inivata
Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer Prospective, interventional study...
Cancer Immunotherapy Market To Reach USD 242.86 Billion By 2026 | Reports And Data
17 juil. 2019 11h02 HE
|
Reports and Data
New York, July 17, 2019 (GLOBE NEWSWIRE) -- Increasing demand for cancer immunotherapy in hospitals, cancer research centers, and clinics coupled with high investment in R&D of cancer...
Non-Small Cell Lung Cancer Market To Reach USD 10.53 Billion By 2026 | Reports And Data
05 juin 2019 11h51 HE
|
Reports And Data
Increase in the understanding of diseases and research into the development of new drugs for non-small cell lung cancer is fueling the market growth. Market Size – USD 6.45 Billion in 2018, Market...
Vaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual Meeting
03 juin 2019 08h00 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., June 03, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and...
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
28 mai 2019 08h57 HE
|
Todos Medical Ltd.
- Data demonstrated strong correlation between LymPro and amyloid PET- Todos to present at Alzheimer’s Solutions Conference on June 3, 2019 in Philadelphia- Todos to present at LD Micro on June 4th,...
Cancer Stem Cell Therapeutics Market To Reach USD 16839 Million By 2026 | Reports And Data
20 mai 2019 13h30 HE
|
Reports And Data
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding...
Vaccinex Announces Poster Presentations at the 2019 ASCO Annual Meeting
15 mai 2019 08h10 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., May 15, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s...
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
01 mai 2019 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel and NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair
12 mars 2019 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...